Home

CTG Home


 News

Latest News


 Secure

Log on
Register



Wednesday 10 Mar 10

TARGIT Trial  

Intrabeam



The recent development of a new technology has made possible the delivery of radiation directly to the tissues at the site of the primary tumour. The INTRABEAM manufactured by Carl Zeiss Surgical GmbH, is a simple but ingenious device, in essence a miniature electron beam-driven X-ray source, which provides a point source of low energy X-rays (50kV max) at the tip of a 3.2mm diameter tube. The radiation source can be inserted into the area of interest immediately after excision of the tumour and switched on for 25-30 minutes to provide intra-operative radiotherapy (IORT), accurately targeted to the tissues that are at highest risk of local recurrence. The physics, dosimetry and early clinical applications of this soft x-ray device have been well studied and the probe has already been used for treatment of human malignant brain tumours. The TARGIT trial is a collaborative international effort to test the hypothesis that the strategy of delivering IORT in patients with low risk early stage breast cancer is equivalent in local recurrence rate to a 6 week course of whole breast radiotherapy.








The System Components for IORT of Breast Tumors:


The Intrabeam Miniature X-ray Source


The radiation dose is provided by a miniature X-ray source PRS 400 that can deliver X-ray energies up to 50kV. The X-ray point-source is ideal for treating from within the tumour or tumour bed. Low energy, high dose rate X-rays are emitted from the source in an isotropic pattern, uniformly irradiating the target tissue.






The Intrabeam Control Console


The Control Console provides the operator interface and delivers low-voltage power to the miniature X-ray source, eliminating high-voltage risks. The miniature X-ray source is verified prior to use, and parameters are then set up within the control console software for treatment delivery. During the procedure, the control console monitors the system for safe and accurate dose delivery.






The Intrabeam Surgical Support System

Mobile and flexible. Functions in any operating room and can easily be transported from one room to another in minutes. The stand offers perfect balancing and six degrees of freedom. Electromagnetic clutches lock the radiation source in the treatment position with millimetre precision. Reliability and performance in a surgical support system.






The Intrabeam Applicators

A complete set of spherical applicators from 1.5 to 5.0 cm in diameter enable accurate placement into the tumour bed, ensuring contact with all surfaces of the treatment area, and uniform dose delivery. The reusable spherical applicators offer convenience and accuracy.








How does it work?

The electrons are generated and accelerated in the main unit and travel via the electron beam drift tube which is surrounded by the conical applicator sheath such that its tip lies at the epicentre of the applicator sphere. Once the electrons hit the inner surface of the hemisphere at the tip, x-rays are generated. Thus a uniform radiation dose rate is available at the surface of the applicator sphere.


















The miniature X-ray source delivers up to 50kV of energy to the target tissue, and the steep dose fall-off ensures that most of the dose stays in the target tissue.




The x-ray source is delivered to the tumour bed utilizing a surgical support stand.  The sterile applicator is joined with a sterile drape that is used to cover the stand during treatment delivery.

Note that the operating room does not need to be adapted or modifed in any way.








Page last modified: 20 Oct 2006